Frontotemporal dementia or frontotemporal lobar degeneration - Overview of a group of proteinopathies;Frontotemporalis dementia vagy frontotemporalis lobaris degeneráció - A proteinopathiák egy csoportjának áttekintése

Ideggyogyaszati Szemle

Volumn 63, Issue 3-4, 2010, Pages 87-93

  Haberland, Catherine ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

Frontotemporal dementia; Frontotemporal lobar degeneration; Proteinopathy 43; Tauopathies; Ubiquitinopathies

Indexed keywords

PROGRANULIN; TAU PROTEIN; ADENOSINE TRIPHOSPHATASE; CDC48 PROTEIN; CELL CYCLE PROTEIN; GRN PROTEIN, HUMAN; MAPT PROTEIN, HUMAN; NERVE PROTEIN; SIGNAL PEPTIDE; UBIQUITIN;

CHROMOSOME 17; CORTICOBASAL DEGENERATION; DISEASE ASSOCIATION; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; HEREDITY; HUMAN; PARKINSONISM; PATHOLOGY; PICK PRESENILE DEMENTIA; PROGRESSIVE SUPRANUCLEAR PALSY; REVIEW; TAUOPATHY; TDP 43 PROTEINOPATHY; BRAIN; DIFFERENTIAL DIAGNOSIS; GENETICS; METABOLISM;

ADENOSINE TRIPHOSPHATASES; BRAIN; CELL CYCLE PROTEINS; CHROMOSOMES, HUMAN, PAIR 17; DIAGNOSIS, DIFFERENTIAL; FRONTOTEMPORAL DEMENTIA; FRONTOTEMPORAL LOBAR DEGENERATION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; NERVE TISSUE PROTEINS; PICK DISEASE OF THE BRAIN; TAU PROTEINS; UBIQUITIN;

EID: 77951641578     PISSN: 00191442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Pick A. Uber die Beziehungen der senilen Hirnatrophie zur Aphasie. Prager Med Wochenschr 1892;17:165-7.
2. Alzheimer A. Uber eigenartiege Krankheitsfalle des spateneren Alters. Z Gesamte Neurol Psychiat 1911;4:356-85.
3. McKhann GM, Albert MS, Grossman M, et al. Clinical and pathological diagnosis of frontotemporal dementia - Report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol 2001;58:1803-9. (Pubitemid 33044246)
4. Vitali P, Migliaccio R, Agosta F, et al. Neuroimaging in dementia. Seminars in Neurology 2008;28:467-83.
5. Bigio EH. Update on recent molecular and genetic advances in frontotemporal lobar degeneration. J Neuropathol Exp Neurol 2008;67:635-48.
6. Cairns NJ, Bigio EH, Mackenzie IR, et al. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: Consensus of the consortium for frontotemporal lobar degeneration. Acta Neuropathol 2007; 114:5-22. (Pubitemid 47029055)
7. Kumar-Singh S, Broeckhoven Van Ch. Frontotemporal lobar degeneration: Current concepts in the light of recent advances. Brain Pathol 2007;17:104-13.
8. Knopman DS, Masti AR, Frey WH, et al. Dementia lacking distinctive histologic features. A common non-Alzheimer degenerative dementia. Neurology 1990;40:251-6.
9. Mackenzie IR, Shi J, Shaw CL, et al. Dementia lacking distinctive histology (DLDH) revisited. Acta Neuropathol (Berl) 2006;112:551-9. (Pubitemid 44550679)
10. Kovacs GG, Majtenyi K, Spina S, et al. White matter tauopathy with globular glial inclusions: A distinct sporadic frontotemporal lobar degeneration. Neuropathol Exp Neurol 2008;67:963-75.
11. Neumann M, Kwong K, Truax AC, et al. TDP-43-positive white matter pathology in frontotemporal lobar degeneration with ubiquitin-positive inclusions. J Neuropathol Exp Neurol 2007;66:177-83. (Pubitemid 46673273)
12. Hiji M, Takahashi T, Fukuba H, Yamashita H, et al. White matter lesions in the brain with frontotemporal lobar degeneration with motor neuron disease: TDP-43-immunopositive inclusions co-localize with p62 but not ubiquitin. Acta Neuropathol 2008;116:183-91.
13. Brandmeir NJ, Geser F, Kwong LK, et al. Severe subcortical TDP-43 pathology in sporadic frontotemporal lobar degeneration with motor neuron disease. Acta Neuropathol 2008;115:123-31. (Pubitemid 50003187)
14. Goedert M. Tau protein and neurodegeneration. Semin Cell Dev Biol 2004;15:45-9. (Pubitemid 38177367)
15. Swieten Van J, Spillantini MG. Hereditary frontotemporal dementia caused by tau gene mutations. Brain Pathol 2007;17:63-73.
16. Neumann M, Sampathu DM, Kwong LK, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006:314;130-33. (Pubitemid 44547757)
17. Arai T, Hasegawa M, Akiyama H, et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 2006;351:602-11. (Pubitemid 44708852)
18. Forman MS, Trojanowski JO, Lee VM. A novel neurodegenerative proteinopathy. Curr Opin Neurobiol 2007;17: 548-55.
19. Sanelli T, Xiao S, Horne P, et al. Evidence that TDP-43 is not the major ubiquitinated target within the pathological inclusions of amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 2007;66:1147-53. (Pubitemid 350294664)
20. Banks GT, Kuta A, Issacs AM, et al. TDP-43 Is a culprit in human neurodegeneration and not just an innocent bystander. Mamm Genome 2008;19:299-305.
21. Benajiba L, Le Ber I, Camuzat A, et al. TARDBP mutations in motoneuron disease with frontotemporal lobar degeneration. Ann Neurol 2009;65:470-73.
22. Pikkarainen M, Hartikainen P, Alafuzoff I. Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions visualized with ubiquitin-binding protein p62 immunohistochemistry. J Neuropathol Exp Neurol 2008;67:280-98. (Pubitemid 351507484)
23. Hatanpaa KJ, Bigio EH, Cairns NJ, et al. TAR DNA-binding protein 43 immunohistochemistry reveals extensive neuritic pathology in FTLD-U: A Midwest-Southwest Consortium for FTLD Study. J Neuropathol Exp Neurol 2008;67:271-9. (Pubitemid 351507483)
24. Mackenzie IR, Baborie A, Pickering-Brown S, et al. Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration. Acta Neuropathol 2006;112:539-49.
25. Sampathu DM, Neumann M, Kwong LK, et al. Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immunohistochemistry and novel monoclonal antibodies. Am J Pathol 2006;169:1343-52. (Pubitemid 351194368)
26. Cairns NJ, Neumann M, Bigio EH, et al. TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. Am J Pathol 2007;171:227-40. (Pubitemid 47342406)
27. Mackenzie IR, Foti D, Woulfe J, et al. Atypical frontotemporal lobar degeneration with ubiquitin-positive, TDP-43- negative neuronal inclusions. Brain 2008;131:1282-93.
28. Gass Y, Cannon A, Mackenzie IR, et al. Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Hum Mol Genet 2006;15:2988-3001. (Pubitemid 44530703)
29. Finch NC, Baker M, Crook R, et al. Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members. Brain 2009;132:583-91.
30. Ghidoni R, Benussi L, Glionna M, et al. Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration. Neurology 2008;71:1235-9.
31. Mackenzie IR. The neuropathology and clinical phenotype of FTD with progranulin mutations. Acta Neuropathol 2007;114:49-54. (Pubitemid 47029059)
32. Josephs KA, Ahmed Z, Katsuse O, et al. Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions with progranulin gene (PGRN) mutations. J Neuropathol Neurol 2007;66:142-51. (Pubitemid 46208735)
33. Gitcho MA, Strider J, Carter D, et al. VCP mutations causing frontotemporal lobar degeneration disrupt localization of TDP-43 and induce cell death. J Biol Chem 2009; 284:1283-98.
34. Holm IE, Englund E, Mackenzie RA, et al. A reassessment of the neuropathology of frontotemporal dementia linked to chromosome 3. J Neuropathol Exp Neurol 2007;66;884-91. (Pubitemid 47530827)
35. Robinson R. Progress on frontotemporal dementia: A blood test is available for progranulin mutations and microRNAs play an important role. Neurology Today 2009;9:24-7.
36. Steinacker P, Hendrich C, Sperfeld AD, et al. TDP-43 in cerebrospinal fluid of patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Arch Neuro 2008;65:1481-7.
37. Kasai T, Tokuda T, Ishigami N, et al. Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Acta Neuropathol 2009;117:55-62.
38. Skoglund L. Molecular mechanisms of frontotemporal lobar degeneration. Uppsala: Acta Universitatis Upsaliensis; 2009.
39. Rademakers R. MicroRNA dysregulation in frontotemporal lobar degeneration. Alzheimer's and Dementia 2009; 5:166.